These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22245285)

  • 1. Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
    Cusick MF; Libbey JE; Trede NS; Eckels DD; Fujinami RS
    J Neuroimmunol; 2012 Mar; 244(1-2):35-44. PubMed ID: 22245285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease.
    Cusick MF; Libbey JE; Trede NS; Fujinami RS
    PLoS One; 2014; 9(4):e94486. PubMed ID: 24718491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
    Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
    Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.
    Iruretagoyena MI; Tobar JA; González PA; Sepúlveda SE; Figueroa CA; Burgos RA; Hancke JL; Kalergis AM
    J Pharmacol Exp Ther; 2005 Jan; 312(1):366-72. PubMed ID: 15331658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent.
    Martiney JA; Rajan AJ; Charles PC; Cerami A; Ulrich PC; Macphail S; Tracey KJ; Brosnan CF
    J Immunol; 1998 Jun; 160(11):5588-95. PubMed ID: 9605164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.
    Dutra RC; de Souza PR; Bento AF; Marcon R; Bicca MA; Pianowski LF; Calixto JB
    Biochem Pharmacol; 2012 Feb; 83(4):531-42. PubMed ID: 22155310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
    Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
    J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
    J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
    Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
    J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congruent effects of estrogen and T-cell receptor peptide therapy on regulatory T cells in EAE and MS.
    Offner H; Vandenbark AA
    Int Rev Immunol; 2005; 24(5-6):447-77. PubMed ID: 16318990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of murine EAE by oral hydrolytic enzyme treatment.
    Targoni OS; Tary-Lehmann M; Lehmann PV
    J Autoimmun; 1999 May; 12(3):191-8. PubMed ID: 10222028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Zhou R; Zhou Y; Dong JR; He PL; Wan H; Li YC; Yang YF; Zuo JP
    J Neuroimmunol; 2006 Jun; 175(1-2):142-51. PubMed ID: 16712960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.